February 2024 Newsletter

24 April 2026
Université Laval and Glycovax Pharma Enter into an Exclusive Global LicenseAgreement for the Development of Innovative Galectin-3 Inhibitors
Université Laval and Glycovax Pharma announce an exclusive global license agreement granting…
Read more
24 April 2026
Stay Compliant for Free: Expert Sexual Harassment Training
Free workplace sexual harassment courses for bio-economy…
Read more
7 April 2026
Announcement of Appointments at the BMC
The Biologics Manufacturing Centre (BMC) Inc. appoints Andy Sheldon as Chief Executive Officer and Elizabeth Douville as…
Read more

More News & publications